| Serial Number | 86028683 |
| Word Mark | KRINGLE PHARMA |
| Filing Date | Monday, August 5, 2013 |
| Status | 711 - CANCELLED - SECTION 7 |
| Status Date | Friday, June 5, 2020 |
| Registration Number | 4545413 |
| Registration Date | Tuesday, June 3, 2014 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Certificate of Correction for Registration | In the statement, line 2, "2F Saito Bio Incuabator" should be deleted, and 2F Saito Bio Incubator should be inserted. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "PHARMA" |
| Goods and Services | Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; Sanitary preparations for medical use; Central nervous system stimulants; Hair growth stimulant; Antipyretic analgesics; Anti-epileptics; Analeptics; Hypnotic sedatives; General anesthetics; Anti-motion sickness preparations; Pharmaceutical preparations acting on the peripheral nervous system; Local anesthetics; Skeletal muscle relaxants; Anhidrotics; Autonomics; Antispasmodics; Diaphoretics; Pharmaceutical preparations acting on the sensory organs; Ophthalmic preparations; Agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; Treatment for eye infection, macular degeneration, retinopathy, rhinitis, and sinusitis; Pharmaceutical antiallergic preparations; Antihistaminics; Cardiovascular treatment preparations; Cardiotonics; Antihypertensives; Vasoconstrictors; Capillary stabilizers; Cerebral hemorrhage prophylactic preparations; Antiarrhythmic preparations; Diuretics; Pharmaceutical preparations acting on respiratory organs; Respiratory stimulants; Anti-cough drops; Antitussive expectorants; Pharmaceutical preparations acting on digestive organs; Gastrointestinal cleaning agents; Clysters; Evacuants (purgatives); Stomachics and digestives; Pharmaceutical preparations for oral use, and for oral inflammation; Emetics; Pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, and alveoloclasia; Antacids; Antiemetics; Castor oil for medical purposes; Cholagogues; Hormones for medical purposes; Thyroid and para-thyroid hormone preparations; Mixed hormone preparations; Estrogen preparations; Pancreas hormone preparations; Salivary gland hormone preparations; Androgen preparations; Pituitary hormone preparations; Adrenal hormone preparations; Pharmaceutical preparations acting on uro-genital and anal organs; Oxytocics; Anti-hemorrhoidals; Emmenagogues; Contraceptives; Medicated skin care preparations; Pharmaceutical preparations for purulence; Anti-dermoinfectives; Antimicrobials for dermatologic use; Astringents; Anti-inflammatory agents; Analgesics; Anti-itchings; Talcum powder for medical purposes; Medicated baby oils; Medicated baby powders; Medicated bath preparations; Vitamin preparations for medical purposes; Cod-liver oil drops for medical purposes; Mixed vitamin preparations for medical purposes; Vitamin A preparations for medical purposes; Vitamin C preparations for medical purposes; Vitamin D preparations for medical purposes; Vitamin B preparations for medical purposes; Multi-vitamin preparations for medical purposes; Amino acid preparations for medical purposes; Threonine preparations; Tryptophane preparations; Methionine preparations; Lysine preparations; Royal jelly for medical purposes; Calcium supplements for medical purposes; Chondroitin preparations for medical purposes; Protein and amino acid preparations for medical purposes; Saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; Mineral preparations for medical use; Anticoagulants; Blood substitutes for human and veterinary use; Blood plasma; Hemostatics; Pharmaceutical preparations affecting metabolism; Antidotes; Enzyme preparations for medical purposes; Lactagogues; Lipotropic factor preparations; Pharmaceutical preparations for the treatment of habitual intoxication; Pharmaceutical preparations for activating cellular function; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for treating physically caused lesions; Pharmaceutical preparations for treating heatstroke; Radiation sickness treating drugs; Pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, and immunosuppresants; Chlorine-detoxication preparations; Arsenic-detoxication preparations; Benzol-detoxication preparations; Antibiotic preparations; Erythromycin preparations; Chloramphenicol preparations; Colistin-polymixin preparations; Sarkomycin preparations; Streptomycin preparations; Thiolutin preparations; Tetracycline preparations; Trichomycin preparations; Mixed antibiotic preparations; Penicillin preparations; Chemotherapeutics; Antisyphilitics; Antituberculous preparations; Sulfonamide preparations; Antileprotic preparations; Biological preparations for medical purposes; Antitoxic sera; Antitoxins; Mixed biological preparations for medical purposes; Preparations for biological tests for medical purposes; Toxoids; Vaccines; Preparations for destroying parasites; Anthelmintics; Odor neutralizing preparations for use on drugs; Pharmaceutical excipients; Diagnostic preparations for medical use; X-ray contrast agents; Diagnostic reagents for medical use; Diagnostic media for bacteriological cultures for medical use; Radio isotope markers for therapeutic or diagnostic use; Opium alkaloid preparations; Synthetic narcotics; Coca alkaloid preparations; Mosquito-repellent incenses; Germicides and fungicides; Rodenticides; Insecticides; Fumigants; Herbicides, namely, weedkillers; Insect-repellents; Antiseptics |
| Goods and Services | Testing, inspection or research of pharmaceuticals and genetics; Medical research; Consultancy and providing information services in the field of testing, inspection or research of pharmaceuticals and genetics; Consultancy and providing information services in the field of medical research; Providing medical and scientific research information and advice in the fields of pharmaceuticals and genetics |
| Pseudo Mark | KRINGLE PHARMACEUTICAL |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, June 5, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, June 5, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KRINGLE PHARMA, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 567-0085 JP |
| Party Name | KRINGLE PHARMA, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka JP |
| Event Date | Event Description |
| Saturday, June 6, 2020 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED |
| Friday, June 5, 2020 | CANCELLED SECTION 7-TOTAL |
| Thursday, April 30, 2020 | REQUEST FOR SECT 7 TOTAL SURRENDER FILED |
| Thursday, June 4, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, April 30, 2020 | TEAS SECTION 7 SURRENDER RECEIVED |
| Wednesday, April 29, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 29, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 29, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, April 29, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, April 29, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 29, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 29, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, June 3, 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, June 2, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 21, 2014 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| Friday, November 21, 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, November 11, 2014 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, November 11, 2014 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 3, 2014 | REGISTERED-SUPPLEMENTAL REGISTER |
| Monday, April 28, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, April 25, 2014 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Thursday, April 24, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 24, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 14, 2014 | ASSIGNED TO LIE |
| Tuesday, April 1, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 21, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 19, 2013 | ASSIGNED TO EXAMINER |
| Tuesday, August 13, 2013 | NOTICE OF PSEUDO MARK E-MAILED |
| Monday, August 12, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 8, 2013 | NEW APPLICATION ENTERED IN TRAM |